{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:33:47Z","timestamp":1678941227913},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00059-022-05160-4","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T10:02:45Z","timestamp":1674727365000},"page":"101-108","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventionelle Therapie der Herzinsuffizienz"],"prefix":"10.1007","volume":"48","author":[{"given":"Peter Moritz","family":"Becher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"5160_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac013","author":"G Savarese","year":"2022","unstructured":"Savarese\u00a0G et\u00a0al (2022) Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvac013","journal-title":"Cardiovasc Res"},{"issue":"16","key":"5160_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","volume":"374","author":"EJ Velazquez","year":"2016","unstructured":"Velazquez\u00a0EJ et al (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N\u00a0Engl J Med 374(16):1511\u20131520","journal-title":"N Engl J Med"},{"issue":"2","key":"5160_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann\u00a0FJ et\u00a0al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart\u00a0J 40(2):87\u2013165","journal-title":"Eur Heart J"},{"issue":"6","key":"5160_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.recesp.2021.11.023","volume":"75","author":"A Vahanian","year":"2022","unstructured":"Vahanian\u00a0A et al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 75(6):524","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"24","key":"5160_CR5","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","volume":"74","author":"M Taramasso","year":"2019","unstructured":"Taramasso\u00a0M et\u00a0al (2019) Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J\u00a0Am Coll Cardiol 74(24):2998\u20133008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5160_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.recesp.2021.11.027","volume":"75","author":"TA McDonagh","year":"2022","unstructured":"McDonagh\u00a0TA et\u00a0al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed) 75(6):523","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"15","key":"5160_CR7","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi\u00a0NL et\u00a0al (2021) Burden of heart failure and underlying causes in 195\u00a0countries and territories from 1990 to 2017. Eur J Prev Cardiol 28(15):1682\u20131690","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"5160_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archinte.168.8.847","volume":"168","author":"GC Fonarow","year":"2008","unstructured":"Fonarow\u00a0GC et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168(8):847\u2013854","journal-title":"Arch Intern Med"},{"issue":"1","key":"5160_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese\u00a0G, Lund\u00a0LH (2017) Global public health burden of heart failure. Card Fail Rev 3(1):7\u201311","journal-title":"Card Fail Rev"},{"issue":"2","key":"5160_CR10","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"Writing Committee M","year":"2022","unstructured":"Writing Committee M et\u00a0al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J\u00a0Am Coll Cardiol 79(2):e21\u2013e129","journal-title":"J Am Coll Cardiol"},{"issue":"8922","key":"5160_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","volume":"344","author":"S Yusuf","year":"1994","unstructured":"Yusuf\u00a0S et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344(8922):563\u2013570","journal-title":"Lancet"},{"issue":"8309","key":"5160_CR12","first-page":"1173","volume":"2","author":"European Coronary Surgery Study Group","year":"1982","unstructured":"European Coronary Surgery Study Group (1982) Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 2(8309):1173\u20131180","journal-title":"Lancet"},{"issue":"6 Pt 2","key":"5160_CR13","first-page":"V102","volume":"72","author":"T Killip","year":"1985","unstructured":"Killip\u00a0T, Passamani\u00a0E, Davis\u00a0K (1985) Coronary artery surgery study (CASS): a\u00a0randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 72(6 Pt 2):V102\u2013V109","journal-title":"Circulation"},{"issue":"1","key":"5160_CR14","doi-asserted-by":"publisher","first-page":"e003255","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","volume":"10","author":"G Wolff","year":"2017","unstructured":"Wolff\u00a0G et al (2017) Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis. Circ Heart Fail 10(1):e3255","journal-title":"Circ Heart Fail"},{"issue":"15","key":"5160_CR15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron\u00a0DJ et\u00a0al (2020) Initial invasive or conservative strategy for stable coronary disease. N\u00a0Engl J Med 382(15):1395\u20131407","journal-title":"N Engl J Med"},{"issue":"8","key":"5160_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJMoa1807365","volume":"381","author":"JA Panza","year":"2019","unstructured":"Panza\u00a0JA et al (2019) Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N\u00a0Engl J Med 381(8):739\u2013748","journal-title":"N Engl J Med"},{"issue":"18","key":"5160_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1161\/CIRCULATIONAHA.116.024800","volume":"134","author":"MC Petrie","year":"2016","unstructured":"Petrie\u00a0MC et al (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (surgical treatment for Ischemic heart failure). Circulation 134(18):1314\u20131324","journal-title":"Circulation"},{"issue":"21","key":"5160_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJM198411223112102","volume":"311","author":"Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group","year":"1984","unstructured":"Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group (1984) Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N\u00a0Engl J Med 311(21):1333\u20131339","journal-title":"N Engl J Med"},{"key":"5160_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1749-8090-5-29","volume":"5","author":"MA Hamad","year":"2010","unstructured":"Hamad\u00a0MA et\u00a0al (2010) Preoperative ejection fraction as a\u00a0predictor of survival after coronary artery bypass grafting: comparison with a\u00a0matched general population. J\u00a0Cardiothorac Surg 5:29","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"5160_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/joic.12497","volume":"31","author":"L Jiang","year":"2018","unstructured":"Jiang\u00a0L et al (2018) Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction. J\u00a0Interv Cardiol 31(3):310\u2013318","journal-title":"J Interv Cardiol"},{"issue":"15","key":"5160_CR21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","volume":"387","author":"D Perera","year":"2022","unstructured":"Perera\u00a0D et\u00a0al (2022) Percutaneous revascularization for ischemic left ventricular dysfunction. N\u00a0Engl J Med 387(15):1351\u20131360","journal-title":"N Engl J Med"},{"issue":"1","key":"5160_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/hrt.35.1.41","volume":"35","author":"S Frank","year":"1973","unstructured":"Frank\u00a0S, Johnson\u00a0A, Ross\u00a0J Jr. (1973) Natural history of valvular aortic stenosis. Br Heart\u00a0J 35(1):41\u201346","journal-title":"Br Heart J"},{"issue":"9986","key":"5160_CR23","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia\u00a0SR et al (2015) 5\u2011year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a\u00a0randomised controlled trial. Lancet 385(9986):2485\u20132491","journal-title":"Lancet"},{"issue":"5\u20136","key":"5160_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00508-017-1297-5","volume":"130","author":"H Baumgartner","year":"2018","unstructured":"Baumgartner\u00a0H (2018) The 2017 ESC\/EACTS guidelines on the management of valvular heart disease: What is new and what has changed compared to the 2012 guidelines? Wien Klin Wochenschr 130(5\u20136):168\u2013171","journal-title":"Wien Klin Wochenschr"},{"issue":"28","key":"5160_CR25","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/eurheartj\/ehv701","volume":"37","author":"Z Samad","year":"2016","unstructured":"Samad\u00a0Z et\u00a0al (2016) Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. Eur Heart\u00a0J 37(28):2276\u20132286","journal-title":"Eur Heart J"},{"issue":"1","key":"5160_CR26","doi-asserted-by":"publisher","first-page":"e001912","DOI":"10.1136\/openhrt-2021-001912","volume":"9","author":"S Ludwig","year":"2022","unstructured":"Ludwig\u00a0S et al (2022) Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI. Open Heart 9(1):e1912","journal-title":"Open Heart"},{"issue":"12","key":"5160_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jacc.2018.01.054","volume":"71","author":"HB Ribeiro","year":"2018","unstructured":"Ribeiro\u00a0HB et al (2018) Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI registry. J\u00a0Am Coll Cardiol 71(12):1297\u20131308","journal-title":"J Am Coll Cardiol"},{"issue":"45","key":"5160_CR28","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","volume":"38","author":"P Genereux","year":"2017","unstructured":"Genereux\u00a0P et\u00a0al (2017) Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart\u00a0J 38(45):3351\u20133358","journal-title":"Eur Heart J"},{"issue":"2","key":"5160_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcmg.2017.01.002","volume":"10","author":"MA Clavel","year":"2017","unstructured":"Clavel\u00a0MA, Burwash\u00a0IG, Pibarot\u00a0P (2017) Cardiac imaging for assessing low-gradient severe aortic stenosis. JACC Cardiovasc Imaging 10(2):185\u2013202","journal-title":"JACC Cardiovasc Imaging"},{"issue":"15","key":"5160_CR30","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2019.08.004","volume":"74","author":"G Strange","year":"2019","unstructured":"Strange\u00a0G et al (2019) Poor long-term survival in patients with moderate aortic stenosis. J\u00a0Am Coll Cardiol 74(15):1851\u20131863","journal-title":"J Am Coll Cardiol"},{"key":"5160_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2016.08.009","volume":"182","author":"E Spitzer","year":"2016","unstructured":"Spitzer\u00a0E et\u00a0al (2016) Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart\u00a0J 182:80\u201388","journal-title":"Am Heart J"},{"issue":"9540","key":"5160_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo\u00a0VT et al (2006) Burden of valvular heart diseases: a\u00a0population-based study. Lancet 368(9540):1005\u20131011","journal-title":"Lancet"},{"issue":"13","key":"5160_CR33","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","volume":"103","author":"F Grigioni","year":"2001","unstructured":"Grigioni\u00a0F et al (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103(13):1759\u20131764","journal-title":"Circulation"},{"issue":"24","key":"5160_CR34","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone\u00a0GW et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N\u00a0Engl J Med 379(24):2307\u20132318","journal-title":"N Engl J Med"},{"issue":"24","key":"5160_CR35","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"Obadia\u00a0JF et\u00a0al (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N\u00a0Engl J Med 379(24):2297\u20132306","journal-title":"N Engl J Med"},{"issue":"24","key":"5160_CR36","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.jacc.2021.10.011","volume":"78","author":"B Koell","year":"2021","unstructured":"Koell\u00a0B et al (2021) Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair. J\u00a0Am Coll Cardiol 78(24):2408\u20132421","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5160_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Y Topilsky","year":"2019","unstructured":"Topilsky\u00a0Y et\u00a0al (2019) Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 12(3):433\u2013442","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"5160_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/hrt.2008.152793","volume":"95","author":"H Song","year":"2009","unstructured":"Song\u00a0H et al (2009) Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart 95(11):931\u2013936","journal-title":"Heart"},{"issue":"3","key":"5160_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath\u00a0J, Foster\u00a0E, Heidenreich\u00a0PA (2004) Impact of tricuspid regurgitation on long-term survival. J\u00a0Am Coll Cardiol 43(3):405\u2013409","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"5160_CR40","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1093\/eurheartj\/ehy434","volume":"39","author":"Y Topilsky","year":"2018","unstructured":"Topilsky\u00a0Y et\u00a0al (2018) Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur Heart\u00a0J 39(39):3584\u20133592","journal-title":"Eur Heart J"},{"issue":"23","key":"5160_CR41","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1136\/heartjnl-2019-315004","volume":"105","author":"AN Kadri","year":"2019","unstructured":"Kadri\u00a0AN et\u00a0al (2019) Outcomes of patients with severe tricuspid regurgitation and congestive heart failure. Heart 105(23):1813\u20131817","journal-title":"Heart"},{"issue":"6","key":"5160_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/ejcts\/ezx279","volume":"52","author":"MJ Antunes","year":"2017","unstructured":"Antunes\u00a0MJ et\u00a0al (2017) Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg 52(6):1022\u20131030","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"5160_CR43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jtcvs.2010.05.050","volume":"141","author":"NR Van de Veire","year":"2011","unstructured":"Van de Veire\u00a0NR et\u00a0al (2011) Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J\u00a0Thorac Cardiovasc Surg 141(6):1431\u20131439","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10213","key":"5160_CR44","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig\u00a0G et al (2019) Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6\u2011month outcomes of the TRILUMINATE single-arm study. Lancet 394(10213):2002\u20132011","journal-title":"Lancet"},{"issue":"15","key":"5160_CR45","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.4244\/EIJ-D-20-01107","volume":"16","author":"G Nickenig","year":"2021","unstructured":"Nickenig\u00a0G et al (2021) Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention 16(15):e1264\u2013e1271","journal-title":"EuroIntervention"},{"issue":"13","key":"5160_CR46","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jcin.2020.03.026","volume":"13","author":"FL Lu","year":"2020","unstructured":"Lu\u00a0FL et al (2020) First-in-man experience of transcatheter tricuspid valve replacement with LuX-valve in high-risk tricuspid regurgitation patients. JACC Cardiovasc Interv 13(13):1614\u20131616","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"5160_CR47","doi-asserted-by":"publisher","first-page":"e014738","DOI":"10.1161\/JAHA.119.014738","volume":"9","author":"MN Young","year":"2020","unstructured":"Young\u00a0MN et\u00a0al (2020) Multidisciplinary heart team approach for complex coronary artery disease: single center clinical presentation. J\u00a0Am Heart Assoc 9(8):e14738","journal-title":"J Am Heart Assoc"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-022-05160-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T16:03:08Z","timestamp":1678896188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-022-05160-4"}},"subtitle":["Stents und Klappen"],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s00059-022-05160-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"19 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.M.\u00a0Becher: Referentenhonorare in den vergangenen 3\u00a0Jahren: Ingelheim Boehringer, Bayer, AstraZeneca. M.\u00a0Seiffert: Referentenhonorare, Forschungsunterst\u00fctzung oder Beratungst\u00e4tigkeit in den vergangenen 3\u00a0Jahren: Abbott Vascular, Abiomed, Amgen, AstraZeneca, Boston Scientific. BMS\/Pfizer, Daiichi Sankyo, Edwards Lifesciences, Inari, Medtronic, Philips, Shockwave Medical, Siemens.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}